Here's the live share price of Rubicon Research along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Rubicon Research has declined 0.09% CAGR. Over the past year, the corresponding return has been -0.44%.
Rubicon Research’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Rubicon Research | -3.55 | -3.9 | -0.44 | -0.44 | -0.44 | -0.15 | -0.09 |
| Sun Pharmaceutical Industries | 0.5 | 7.43 | 14.93 | 9.21 | 1.03 | 20.57 | 26.17 |
| Divi's Laboratories | -1.11 | -5.6 | 4.6 | -3.01 | 2.56 | 23.98 | 11.58 |
| Torrent Pharmaceuticals | 1.8 | 6.33 | 5.75 | 21.31 | 13.54 | 32.96 | 23.34 |
| Cipla | -0.22 | 1.17 | -3.58 | 3.33 | 1.34 | 10.89 | 14.69 |
| Dr. Reddy's Laboratories | 2.32 | 6.55 | 2.08 | 2.18 | 5.26 | 12.62 | 5.45 |
| Lupin | 0.94 | 4.69 | 7.87 | 7.67 | -0.46 | 39.53 | 17.53 |
| Zydus Lifesciences | -0.2 | -3.85 | -7.57 | 0.43 | -3.6 | 31.31 | 14.71 |
| Mankind Pharma | -1.67 | -6.67 | -13.82 | -5.77 | -14.86 | 15.8 | 9.2 |
| Aurobindo Pharma | -1.02 | 6.31 | 18.2 | 7.46 | -2.73 | 37.96 | 6.33 |
| Alkem Laboratories | -3.25 | -2.77 | 3.84 | 13.16 | -2.83 | 20.9 | 14.04 |
| Abbott India | -2.12 | -1.84 | -10.47 | -7.85 | -0.04 | 12.85 | 13.59 |
| Glenmark Pharmaceuticals | 1.75 | 7.06 | -0.68 | 30.48 | 27.73 | 65.57 | 31.47 |
| Laurus Labs | 0.74 | 2.93 | 15.86 | 62.37 | 73.43 | 34 | 24.99 |
| Biocon | -2.83 | 2.1 | 8.78 | 15.46 | 2.24 | 11.64 | -2.59 |
| GlaxoSmithKline Pharmaceuticals | -0.65 | -5.96 | -11.89 | -26.98 | 4.21 | 23.15 | 10.02 |
| Anthem Biosciences | 5.57 | -5.77 | -21.56 | -9.36 | -9.36 | -3.22 | -1.95 |
| Ipca Laboratories | 4.53 | 12.48 | 8.87 | 4.24 | -2.17 | 19.06 | 5.31 |
| Ajanta Pharma | 3.48 | 0.33 | 0.72 | 1.27 | -12.36 | 27.56 | 19.78 |
| J B Chemicals & Pharmaceuticals | 3.39 | 7.75 | 6.23 | 7.74 | 1.07 | 21.9 | 29.77 |
Over the last one year, Rubicon Research has declined 0.44% compared to peers like Sun Pharmaceutical Industries (1.03%), Divi's Laboratories (2.56%), Torrent Pharmaceuticals (13.54%). From a 5 year perspective, Rubicon Research has underperformed peers relative to Sun Pharmaceutical Industries (26.17%) and Divi's Laboratories (11.58%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 651.58 | 642.63 |
| 10 | 670.59 | 651.5 |
| 20 | 662.93 | 650.4 |
| 50 | 398.71 | 0 |
| 100 | 199.36 | 0 |
| 200 | 99.68 | 0 |
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 21,24,913 | 0.22 | 131.35 | |
| 13,30,360 | 0.13 | 77.3 | |
| 7,21,680 | 0.69 | 44.61 | |
| 5,16,027 | 1.15 | 29.98 | |
| 3,72,780 | 0.82 | 23.04 | |
| 3,17,002 | 0.75 | 19.6 | |
| 3,09,270 | 1.35 | 19.12 | |
| 2,85,000 | 0.28 | 17.62 | |
| 2,22,060 | 0.46 | 13.73 | |
| 1,87,442 | 1.2 | 11.59 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 21, 2025, 12:31 AM IST | Rubicon Research - Intimation For Updation Of Corporate Identification Number ("CIN") Of The Company |
| Nov 19, 2025, 12:01 AM IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 14, 2025, 6:33 PM IST | Rubicon Research - Newspaper Publication - Financial Results |
| Nov 13, 2025, 11:52 PM IST | Rubicon Research - Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, 13Th November 2025 |
| Nov 13, 2025, 11:48 PM IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Investor Presentation |
Rubicon Research Ltd. is a Public Limited Listed company incorporated on 06/05/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U73100MH1999PLC119744 and registration number is 119744. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1073.84 Cr. and Equity Capital is Rs. 15.41 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rubicon Research is ₹624.70 as on Dec 04, 2025.
The Rubicon Research is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Rubicon Research is ₹10,291.95 Cr as on Dec 04, 2025.
Today’s highest and lowest price of Rubicon Research are ₹633.15 and ₹620.35.
The 52-week high/low is the highest and lowest price at which Rubicon Research stock has traded in the past 52-week or nearly a year. The 52-week high of Rubicon Research is ₹754.80 and 52-week low of Rubicon Research is ₹570.75 as on Dec 04, 2025.
The Rubicon Research has shown returns of -1.0% over the past day, -3.9% for the past month, -0.44% over 3 months, -0.44% over 1 year, -0.15% across 3 years, and -0.09% over 5 years.
P/E ratio of and PB ratio of Rubicon Research are 0.00 and 17.31 on Dec 04, 2025. While the company gives a dividend yield of 0.00 per annum.